noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

Science

Saladax Biomedical Inc

Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy[...]
Immunomic Therapeutics Inc

2023 Cell and Gene Therapy on the Mesa, October 10-12, Carlsbad, CA
MIT - Massachusetts Institute of[...]

How the biggest Alzheimer’s risk gene disrupts the process of[...]

Company News

Immunomic Therapeutics Inc

11/07/2024 | Press release | Archived content

ITI’s Poster Presentation at SITC 39th Annual Meeting 2024

Immunomic Therapeutics Announces Presentation on Self-amplifying RNA vaccines using the UNITE® platform for Triple-negative Breast Cancer at SITC 39^th Annual Meeting 2024

Click here for details: https://ow.ly/Se7750U1mUt

Immunomic Therapeutics Inc published this content on November 07, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 02, 2026 at 11:06 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format